Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Fatigue and Comorbidities in Multiple Sclerosis.
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
Episode 24 with Professor Aksel Siva discussing asymptomatic MS
[Immunomodulation and neuroprotection in optic neuritis].
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Biogen Idec receives notification of PDUFA date extension
Prevalence of Multiple Sclerosis in the Republic of Moldova.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Overview of the immune system.
Extended interval dosing of natalizumab in multiple sclerosis.
Brain and BrainPET 2015
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
Epigenetics of Multiple Sclerosis: An Updated Review.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Autoimmune sleep disorders.

Pages